SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 41 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $167,000 | -36.7% | 636,784 | 0.0% | 0.00% | – |
| Q1 2020 | $264,000 | -38.0% | 636,784 | -49.7% | 0.00% | – |
| Q4 2019 | $426,000 | -3.8% | 1,265,294 | +105.5% | 0.00% | – |
| Q3 2019 | $443,000 | +27.7% | 615,734 | +28.7% | 0.00% | – |
| Q2 2019 | $347,000 | -9.2% | 478,478 | +51.9% | 0.00% | – |
| Q1 2019 | $382,000 | +185.1% | 314,975 | -3.3% | 0.00% | – |
| Q4 2018 | $134,000 | -58.8% | 325,764 | +100.0% | 0.00% | – |
| Q3 2018 | $325,000 | +2.2% | 162,882 | +8.6% | 0.00% | – |
| Q2 2018 | $318,000 | -14.7% | 150,040 | +9.4% | 0.00% | – |
| Q1 2018 | $373,000 | -19.4% | 137,196 | +9.3% | 0.00% | – |
| Q4 2017 | $463,000 | +292.4% | 125,489 | +105.2% | 0.00% | – |
| Q3 2017 | $118,000 | -28.5% | 61,146 | 0.0% | 0.00% | – |
| Q2 2017 | $165,000 | -35.3% | 61,146 | -1.9% | 0.00% | – |
| Q1 2017 | $255,000 | +24.4% | 62,353 | +9.8% | 0.00% | – |
| Q4 2016 | $205,000 | -17.0% | 56,782 | +0.2% | 0.00% | – |
| Q3 2016 | $247,000 | – | 56,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|